Can cannabis calm Alzheimer's agitation? new trial seeks answers
Symptom relief
Recruiting now
This study tests an oral medication called IGC-AD1, made from a cannabis compound (THC), to see if it can safely reduce agitation in people with mild to severe Alzheimer's disease. About 164 participants will take the drug or a placebo twice daily for several weeks. The goal is t…
Phase: PHASE2 • Sponsor: IGC Pharma, LLC • Aim: Symptom relief
Last updated Apr 29, 2026 09:48 UTC